Richard Clark (pharmacologist)
 |
This biographical article needs additional citations for verification. Please help by adding reliable sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately, especially if potentially libelous or harmful. (May 2009) |
Richard T. Clark is the Chairman of Merck Pharmaceutical Company, a position held since 2007. Mr Clark's previous leadership positions at Merck include CEO (2005-2010)[1], President (2005-2009), and President of the Merck Manufacturing Division (2003-2005).
Born in 1946, graduated from Washington & Jefferson College (1968), MBA from American University (1970), Lieutenant in US Army (1970–1972) employed by Merck since 1972.
He has served on the Washington & Jefferson College Board of Trustees.[2]
[edit] Compensation
While CEO of Merck in 2008, Richard T. Clark earned a total compensation of $17,320,938, which included a base salary of $1,783,334, a cash bonus of $2,244,510, stocks granted of $6,811,125, options granted of $6,408,300, and other compensation of $73,669.[3]
|
||||||||||||||
2% [edit] Notes
- ^ Merck Board Elects Kenneth C. Frazier as Next CEO; Richard T. Clark to Continue as Chairman, Merck & Co., Inc
- ^ "W&J: Board of Trustees". W&J College Website. Washington & Jefferson College. http://www.washjeff.edu/content.aspx?section=1352&menu_id=378&crumb=649&id=90. Retrieved 2010-02-28.
- ^ 2008 CEO Compensation for Richard T. Clark, Equilar.com
